-
COVID is surging, but new vaccines have been approved. Here’s what to know
-
The Ohio Department of Health is tracking both the mosquito-borne West Nile virus and COVID.
-
-
Health, Science & Environment
-
-
Some people have had trouble getting Paxlovid pills quickly, despite the administration's effort to ease access after a COVID test confirms infection.
-
The antiviral pills must be taken within five days of COVID-19 symptoms starting, but patients in the Cleveland area have had some problems figuring out how to access them.
-
Politics, religion, distrust and disinformation all play a role. "I've realized that there's no convincing somebody once they have their mind made up," says a social worker in Beaumont, Texas.
-
The chance of dying after receiving the Janssen vaccine is about 1:2,000,000. But with multiple COVID-19 vaccines available, the FDA is limiting the use of the J&J vaccine.
-
Andy Slavitt, former senior adviser to President Biden on COVID-19, shares what he thinks the endemic phase of COVID-19 will look like in the U.S. and how we can prepare for that stage now.
-
Starting on Monday, May 9, students faculty and staff not showing any COVID symptoms will no longer have to submit to weekly testing.
-
As many as 800,000 Ohioans are still battling COVID symptoms more than 2 years after their initial diagnosis.
-
Health, Science & EnvironmentThe Centers for Disease Control and Prevention reports that for the 2020-21 school year, vaccine coverage fell slightly from the year before, elevating fears of outbreaks of childhood illnesses.
-
The company says a low-dose version of its vaccine triggers an immune response in children ages 6 months to less than 6 years equivalent to what has protected older children and adults.
-
With the BA.2 subvariant of omicron pushing infection rates up, many are reaching for at-home rapid tests. Here's what experts say on how best to use them.
Latest Coronavirus Stories
-
Highland County Judge Rocky Coss and his statewide committee made 100 recommendations to the Ohio Supreme Court including remote hearings and testimony
-
Health officials argue the protection of the COVID vaccine booster wanes over time and say some people need a second booster. But other infectious disease experts say three shots are enough for now.
-
People who are 50 and older and certain immunocompromised individuals may get a second Pfizer-BioNTech or Moderna COVID-19 vaccine booster four months after they received the first.
-
Though findings are preliminary, many studies suggest that vaccinated people have good protection against the condition, although just how much is still up for debate.
-
No deaths were reported in tests, and there were no signs of myocarditis, or heart inflammation, as a side effect.
-
The Ohio wastewater monitoring program's goal is to measure the amount of COVID-19 genetic matter in stool in order to alert local health officials of impending surges, but the data lags, officials say.
-
While approval would only be for those populations, an infectious disease specialist from Mount Carmel Medical Group says may be good for everyone.
-
If approved, this would be the second booster shot Moderna has issued for people ages 18 and up.
-
Cleveland Clinic detected the highly contagious subvariant in its labs a few weeks ago that is causing a surge of cases in Europe. But health officials say it does not seem to be driving any local surges in new cases yet.
-
Pfizer and BioNTech are planning to ask the Food and Drug Administration to authorize a second COVID-19 booster shot for people age 65 and older.